Bio Plus Past Earnings Performance
Past criteria checks 2/6
Bio Plus has been growing earnings at an average annual rate of 21%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 14.7% per year. Bio Plus's return on equity is 19.9%, and it has net margins of 39.3%.
Key information
21.0%
Earnings growth rate
19.6%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 14.7% |
| Return on equity | 19.9% |
| Net Margin | 39.3% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How Bio Plus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 65,043 | 25,581 | 9,195 | 1,165 |
| 30 Sep 23 | 65,368 | 24,880 | 8,521 | 1,195 |
| 30 Jun 23 | 61,976 | 24,636 | 7,459 | 1,205 |
| 31 Mar 23 | 57,103 | 22,668 | 6,696 | 1,089 |
| 31 Dec 22 | 56,719 | 21,137 | 6,269 | 1,081 |
| 30 Sep 22 | 51,353 | 18,394 | 5,435 | 908 |
| 30 Jun 22 | 45,282 | 12,217 | 5,330 | 618 |
| 31 Mar 22 | 40,612 | 11,269 | 5,222 | 543 |
| 31 Dec 21 | 37,418 | 10,725 | 4,607 | 435 |
| 30 Sep 21 | 35,084 | 10,321 | 4,807 | 462 |
Quality Earnings: A099430 has a high level of non-cash earnings.
Growing Profit Margin: A099430's current net profit margins (39.3%) are higher than last year (37.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A099430's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A099430's past year earnings growth to its 5-year average.
Earnings vs Industry: A099430 earnings growth over the past year (21%) exceeded the Medical Equipment industry 8.8%.
Return on Equity
High ROE: A099430's Return on Equity (19.9%) is considered low.